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Between Single and Double Catheter Strategy During Right Transradial
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Pierfrancesco Agostoni2, Salvatore Saccà1, Garami Zsolt3, Francesco Versaci1,
Bernhard Reimers1
1Cardiology Department, Ospedale Civile, Mirano, Mirano, Italy, 2University
Medical Center Utrecht, Utrecht, Netherlands, 3Methodist Hospital, Houston,
Houston, TX
Background: Silent cerebral embolization,detected at transcranial Doppler (TCD)
monitoring as microembolic signals (MES), is common during diagnostic coronary
angiography (DCA). MES rate depends on degree of intravascular catheter manipulation.
When using Judkins catheters, right transradial approach (RTA) showed higher rate of
MES compared to left transradial and transfemoral, as a consequence of higher rate of
catheter exchanges due to difficult navigation and manipulation through tortuous innom-
inate arteries. Microembolization is more common in the right cerebral emisphere,
according to origin of right common carotid artery from innominate artery. A single
catheter fitting both coronaries (Optitorque Tiger, Terumo,Japan) is available and could
reduce the embolization rate. Our aim was to compare cerebral embolization of single
(SC) vs double catheters (DC) strategy during DCA performed through RTA.
Methods: 19 patients with suspected coronary artery disease were submitted to DCA via
RTA after randomization to single (Optitorque Tiger,n9) or double (Judkins Left and
Right,n10) catheter strategy, with contemporaneous bilateral TCD monitoring to detect
a 50% reduction of MES.
Results: Less catheters were employed in SC compared to DC group (1.1	/0.3 vs
2.1	/0.3,p0.0001) with similar procedural success rate (88% vs 90%,p0.9). MES
were detected in all patients, with a significant lower rate in SC group (median 30,
interquartile range (IQR) 16-45, vs 57,IQR 54-69,p0.0001), especially during catheters
exchange (19,IQR 11-25 vs 41,IQR 27-49,p0.003), whereas no difference was detected
during contrast injections (5,IQR 1-13 vs 9,IQR 5-17,p0.24) and coronary ostia
engagement (2,IQR 1-6 vs 8,IQR 1-11,p0.15). A strong negative correlation exists
among number of MES and SC strategy (Spearman’s 0.78, p0.0001); at multi-
variate linear regression analysis the use of a single catheter reduced incidence of MES of
50% (B30,std error7,beta0.7,t4,95% IC46/15, p0.001, costant61).
Conclusions: RIsk of silent brain injury during DCA is strongly related to number of
catheters employed. A specifically designed diagnostic catheter for both coronary arteries
via RTA reduced dramatically this embolic risk.
TCT-401
A Comprehensive Easily Applicable Approach to Graduation of Radial Artery
Spasm Related to Transradial Interventions
Tim Schäufele1, Artemisia Karagianni1, Ina Wenzelburger1, Ali Yilmaz1,
Udo Sechtem1
1Robert-Bosch-Krankenhaus, Stuttgart, Germany
Background: A common complication of Transradial approach (TRA) is radial artery
spasm (RAS), which is a predictor of procedural failure and might influence radial artery
occlusion. To date no clinical graduation of RAS exists. The aim of this study was to
provide a comprehensive, yet easily applicable graduation of RAS which might serve as
a tool to predict procedural failure and vessel patency
Methods: In 336 coronary angiographic procedures performed from January 2010 to
May 2012, 243 patients received no spasm prophylaxis (SP), in 93 cases a combination
of 0.2mg of nitroglycerin and 2.5mg of diltiazem was injected intraarterially. Patient
characteristics were: SP naïve group (SPN): Mean age 6211 yrs., BMI 285kg/m2; SP
group(SPP): mean age 6210 yrs., BMI 285kg/m2. Spasm was characterized by
maneuverability of catheters and perception of manipulation by patient (pt) as follows: 0
Operator (op) perceives no noticeable resistance when manipulating catheter, pt may
perceive movement but no pain I op perceives some resistance, maneuverability is not
influenced, pt perceives movement but no pain II op perceives some resistance,
maneuverability is not influenced, perception for pt unpleasant but tolerable III catheter
still effectively maneuverable, distinct painful perception by pt IV no effective
maneuvering of catheter possible, catheter still retractable, distinct painful perception by
pt V catheter not steer- or retractable, pt experiences severe pain when catheter is
manipulated.
Results: Fluoroscopy time was equal in both groups: SPN 4.22 minutes; SPP 4.23
minutes (pns). Success rate was 97.3%. Occurrence of the different degrees of RAS is
shown in table 1.
Table 1: Frequency of RAS following 6 degrees of severity
Degree
0
Degree
I
Degree
II
Degree
III
Degree
IV
Degree
V
Spasm Prophylaxis
naive Patients
22.4%
n54
17.3%
n42
32.9%
n80
18.1
n44
7.8%
n19
1.6%
n4
Patients who
reveived Spasm
Prophylaxis
64.5%
n60
11.8%
n11
15.1%
n14
2.2%
n2
6.5%
n6
0%
n0
p0.01 p0.01 p0.01 p0.01 p0.01 p0.01
Conclusions: The proposed graduation of RAS can easily be used as only 2 clinical
parameters need to be evaluated. Further investigation is needed to elucidate the predictive
value for procedural failure and radial artery occlusion.
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Background: The feasibility, safety and efficacy between TR and TF approach for
coronary interventional treatment have been compared in some complicated situations
including AMI, unprotected left main coronary artery disease. However, in terms of triple
vessel disease intervention, there is still no comparison regarding procedural and
long-term outcomes between TR and TF approach.
Methods: Totally 5351 consecutive patients(TR:4124,TF1227), who were diagnosed as
triple vessel disease without LM involved by angiography and underwent percutaneous
revascularization, were prospectively enrolled in the study. Procedural results and clinical
outcome were obtained. In order to diminish the selective bias between the two gurops,
we used propensity score matching method and got 892 pairs of patients with comparable
baseline data to compare the procedural and long-term outcome between TR and TF
group.
Results: After propensity score matching, clinical and angiographic characteristics were
similar between the two groups. No significant difference were observed between the two
groups for procedural success rate (TR 99.8% vs TF 99.9%, p0.62), total fluoro time
(TR 14.54 10.99min vs TF15.35 10.36min, p0.11), contrast volume (TR 166.34
94.97 min vs TF171.60 96.86 min, p0.40). However, duration of hospitalization
(TR 7.494.46 days vs TF8.636.23 days, p0.0001), in-hospital occurrence of TIMI
bleeding (TR 1.0% vs TF 2.9, p0.003) were significant lower with TRI. Acording to
clinical follow-up, cumulative rates of MI (TR 2.9% vs TF 3.3%, p0.68), TVR (TR
6.1% vs TF 7.7%, p0.16), all thrombosis (TR 4.3% vs TF 4.7%, p0.64) did not
stastically differ in the two groups. However, all cause mortality (TR 1.8% vs TF 3.7%,
p0.01) and MACE(TR 10.2% vs TF 13.7%, p0.02) were significant lower with TRI.
Conclusions: As compared to TFI, TRI for triple vessel disease intervention is feasible
,safe and associated with similar procedural success, abbreviated hospitalization, reduced
bleeding ,lower incidence of death and MACE, and comparable long term efficacy.
TCT-403
Percutaneous Ultrasound-Guided Thrombin Injection as a Safe and
Efficacious Primary Treatment of Iatrogenic Femoral Pseudoaneurysms for
the Interventional Cardiologist
Daniel Chen1, Anthony Sammel1, Pankaj Jain2, Nigel Jepson1, Paul Batt1
1Prince of Wales Hospital, Sydney, Australia, 2Royal North Shore Hospital,
Sydney, Australia
Background: Iatrogenic femoral pseudoaneurysms (IFP) complicate up to 8% of cardiac
catheterization procedures. Percutaneous ultrasound-guided thrombin injection (PUTI)
remains a second line treatment after ultrasound-guided manual compression and open
surgical repair in many centers despite high efficacy, short time to thrombosis, and low
complication rates.
Methods: A retrospective review was undertaken of 121 consecutive cardiac patients
who received PUTI as primary treatment for IFP following cardiac diagnostic, coronary
interventional or electrophysiological procedures between 1999 and 2011 at a tertiary
cardiac referral center. The mean patient age was 70.7 years (range 38-90 years) and 63%
were male. At the time of injection, 89% were on an antiplatelet or therapeutic
anticoagulant agent, of which 9% were on combination antiplatelet and anticoagulant
therapy. Pseudoaneurysms had a mean maximum dimension of 26.7mm (range 10-
122mm), 25% were multilobular. PUTI was performed by an interventional cardiologist
with a mean bovine thrombin dose of 648 IU (range 50-5000 IU).
Results: Primary success (immediate IFP thrombosis) with PUTI was achieved in 111
(92%) patients. Recurrence occurred in six patients, three of whom required surgical
repair. Multilobular IFP had significantly lower primary success rates than unilobular IFP
(80% vs 96%, p  0.016). Antiplatelet and anticoagulant use and IFP size did not
significantly affect the primary outcome. No serious complications were observed,
including thromboembolism, limb ischemia, aneurysm rupture, or abscess formation.
Conclusions: Interventional cardiologist-operated PUTI should be considered as first line
therapy for all uncomplicated IFPs post cardiac catheterization and intervention. It is a
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highly effective and safe primary treatment modality. Initial thrombosis rates exceeded
90% and no serious complications were observed in this series despite a high rate of
concomitant antiplatelet and antithrombotic therapy.
TCT-404
Efficacy and Safety of Total Percutaneous Femoral Closure Following Stent
Graft Implantation Using Preclose Technique
Won Ho Kim1, Sanghoon Shin2, Byeong-Keuk Kim2, Young-Guk Ko2,
Myeong-Ki Hong2, Yangsoo Jang2, Donghoon Choi2
1Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea,
Republic of, 2Yonsei Cardiovascular Hospital, Yonsei University College of
Medicine, Seoul, Korea, Republic of
Background: The preclose technique with the 6 F Proglide for complete percutaneous
endovascular aortic repair have not been sufficiently evaluated. We investigated the
efficacy and safety of the preclose technique in a sufficient and large cases.
Methods: The medical records of 367 patients with 599 preclose techniques for various
aortic repairs were reviewed. Procedural success was defined as hemostasis achieved by
the preclose technique, without the need for surgical or endovascular procedures. Access
related major adverse event (ARMAE)s were considered as those event, such as infection,
bleeding, new onset ischemia of the lower leg, hematoma, pseudoaneurysm, arteriovenous
fistula, embolization, laceration, femoral artery thrombosis, nerve injury, or death by
access site injury.
Results: Procedural success was achieved in 359 of 367 patients (97.8%) and 591 of 599
left or right femoral sites (98.7%). All cases of procedural failure were treated by
immediate surgical repair of femoral arteries. The preclose technique was more successful
in the smaller sheath. ARMAEs developed in 25 of 367 patients (6.8%) and 26 of 599
sites (4.3%). Access site hematoma was the most frequent adverse events (16 of 367
patients (4.4%) and 17 of 599 sites (2.8%)), followed by puncture site pseudoaneurysm (7
of 367 patients (1.9%) and 7 of 599 sites (1.2%)). Bleeding after arterial closure occurred
in 6 of 367 patients (1.6%) and 6 of 599 sites (1.0%). In 2 of 367 patients (0.5%), there
was an infection at the puncture site. There were two cases of distal embolization, one case
of acute femoral thrombosis, and one case of a vascular laceration at the puncture site.
There were no access site related nerve injury, arteriovenous fistula or death complicated
by access site.
Conclusions: The preclose technique can be used to achieve hemostasis for stent graft
procedure successfully, with a high rate of procedural success and an acceptable rate of
adverse event, the most common being puncture site hematoma formation.
TCT-405
Transradial approach decreases in-hospital mortality in patients with
cardiogenic shock. A single-center experience
Oriol Rodriguez-Leor1, Eduard Fernandez-Nofrerias1, Xavier Carrillo1,
Josepa Mauri1, Carolina Oliete1, Carmen Rivas1, Antoni Bayes-Genis1
1HU Germans Trias i Pujol, Badalona, Spain
Background: Transradial approach (TRA) in percutaneous coronary intervention (PCI)
has increased over the past few years. Its use has been shown to decrease mortality
compared with the transfemoral approach (TFA) in patients with acute coronary
syndrome (ACS). Comparative studies have systematically excluded patients with
cardiogenic shock (CS).
Methods: We carried out a prospective, observational registry study of consecutive
patients undergoing emergent revascularization between February 2007 and January
2012. An analysis of the clinical evolution of patients with CS during hospitalization was
performed according to the approach used in the PCI.
Results: Of 1,400 emergency procedures, 122 had CS, 80 underwent PCI by TRA
(65.6%) and 42 by TFA (34.3%). The main reason for choosing TFA was the absence of
radial pulse (54.9%). Mortality (64.3% vs. 32.5%, p0.001), serious access site
complications (11.9% vs. 2.5%, p0.03) and MACE (combination of death, infarction,
stroke, serious bleeding, and postanoxemic encephalopathy) (73.8% vs. 43.8%, p0.001)
were greater in TFA patients. In the multivariate analysis, TRA was a predictor of
mortality (OR 0.39[0.15-0.97]); other predictive factors were age75 (3.47[1.35-8.92]),
previous treatment with diuretics (3.67[1.21-11.12]) and the success of the procedure
(0.08[0.02-0.24]).
Conclusions: In centers with experience, TRA approach for PCI is possible and safe in
patients with CS in up to two thirds of the patients. The main cause that prevented the use
of TRA was the absence of radial pulse. In the multivariate analysis, TRA was associated
with a lower risk of mortality.
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Trans-radial balloon aortic valvuloplasty
Steven Goldberg1, Creighton Don2
1University of Washington Medical Center, Seattle, WA, 2University of
Washington, Seattle, WA
Background: Ballooon aortic valvulplasty can be useful for palliation of symptoms in
pts not eligible for surgical or transcatheter aortic vaalve replacement, or a a bridge to
AVR. Occassionally transfemoral access is impossible or challenging, due to vascular
disease or morbid obesity. We present our experience with trasnradial access for balloon
aortic valvulplasty in pts not candidates for transfemoral approach.
Methods: 5 pts presented with critical aortic stenosis without femoral access. Transradial
access was successfully obtained in all pts. In 1 pt a vascular loop prompted a change from
the right to the left radial approach - the others were done via right radial access. Internal
jugular venous access was used for PA catheter and pacing. After crossing the aortic valve
using 6Fr amplatz 1 catheter with straight wire, and changing out for a dual lumen pigtail.
Over an exchange length wire, the 6 Fr sheath was excheanged for an 8 Fr, and a 22 mm
Tyshack balloon was advanced across the aortic valve and dilated during rapid pacing.
Due to inadequate hemodynamics, in 1 case the 8 Fr sheath was exchanged for a 9 Fr, and
a 25 mm Tyshack balloon used.
Results: In 4 of 5 pts aortic valvuloplasty was attempted and successfully performed. In
1 pt with morbid orbesity vigourous diuresis was instead successful in treating his CHF
and one year later he underwent successful surgical AVR. 1 of the pts with successful
balloon valvuplasty had occlusive lower extremity arterial disease and need for warfarin
for a mechanical mitral valve, the others had morbid obesity (mean weight 168 kg). All
pts had hemodynamic improvement, mean AV gradient decreased from 47 to 36 (23%),
and AVA increased from 0.85 to 1.1 (29% increase). The pt with 9 Fr sheath had small
amount of tissue removed with removal of the 9 Fr sheath, but no clinical complications
in any pt.
Conclusions: Radial artery access is a feasible option for the performance of balloon
aortic valvuloplasty in patients with poor femoral artery access.
TCT-407
Vascular Hemostasis Devices: Food And Drug Administration Perspective On
Reported Risks
Roberta Sullivan1, Deborah Yoder1
1FDA/CDRH, Silver Spring, MD
Background: Vascular Hemostasis Devices (VHD) are regulated by FDA as high-risk
Class III medical devices requiring Pre-Market Approval (PMA). First approved in 1995,
these devices have evolved and been broadly adopted for hemostasis use, with current use
estimates up to 50% of all coronary procedures. FDA databases were searched to provide
a regulatory summary and device profile overview.
Methods: The PMA, Adverse Event, Recall, Registration and Inspection databases were
searched using the device product code and years 2007 through 2011. Statistical testing
used t-test and X2, as appropriate for proportions or means, with significance level of 0.05.
Results: The FDA registration and listing database identified 8 different manufacturers
and 11 different devices. FDA approval of the 11 devices occurred from 1995 through
2011. 10 of the 11 listed devices are made in the US by US manufacturers. Two
manufacturers represented 95% of the VHDs reported in adverse events. The number of
annual adverse events reports increased 300% from 1,402 in 2007 to 4,243 in 2011, with
a five year total of 14,120 reports received. Geographically, 72% of the adverse events
occurred in the US and 27% in 53 other countries. Females were disproportionately
represented (p 0.001, 44% vs. 34% expected). Patient age ranged from 4 to 98 years,
with women found to be older than men (65.8 vs. 64.7, p0.01). A total of 164 reports
for death as the patient outcome were received. For women, deaths were present in 3.38%
of the reports compared to 1.28% for men (p0.001, odds ratio 2.7 [CI 1.908, 3.802]).
During the timeframe there was one US recall for a compromised sterility issue and one
foreign recall for increased failure rates. US Manufacturer and contractor inspections
included four cases of FDA citations requiring actions.
Conclusions: Reasons women experience higher risks are not known but appear to
persist despite product experience and design changes. More research on gender
differences and device design is recommended. Increased overall numbers of VHD
adverse event reports to FDA likely parallels temporal increases in use. Limitations relate
to missing data for patient age and gender, and known underreporting of adverse events.
TCT-408
Sheathless Guide Catheters in complex Transradial PCI. A Single Center
Experience
Raul Valdesuso1, Francisco Lacunza1, Juan Gimeno1, Juan Garcia de Lara1,
Jose Hurtado1, Eduardo Pinar1, Mariano Valdes1
1Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
Background: The Sheathless Guiding Catheter (SGC) (Sheathless Eaucath, Asahi Intecc
Co, Japan) has Hydrophilic coatings that enhances catheter tractability through tortuous
vessels and allow dealing with radial spasm and performing Percutaneous Coronary
Intervention (PCI) by radial approach in complex cases. We reported our experience in 91
patients (pts) with complex transradial approach in whom SGC was used to avoid femoral
cross over to complete the procedure.
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